申请人:Dynogen, Inc.
公开号:US20040254171A1
公开(公告)日:2004-12-16
The invention relates to a method of treating nausea, vomiting, retching or any combination thereof in a subject in need of treatment. The method comprises administering to a subject in need of treatment a therapeutically effective amount of a compound that has 5-HT
3
receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity. The invention further relates to a method of treating nausea, vomiting, retching or any combination thereof in a subject in need thereof, comprising coadministering to said subject a first amount of a 5-HT
3
antagonist and a second amount of a NARI, wherein the first and second amounts together comprise a therapeutically effective amount or are each present in a therapeutically effective amount. In addition, the method of the invention comprises administering a NARI alone.
本发明涉及一种治疗需要治疗的对象的恶心、呕吐、反胃或其任何组合的方法。该方法包括向需要治疗的受试者施用治疗有效量的化合物,该化合物具有 5-HT
3
受体拮抗剂活性和肾上腺素再摄取抑制剂(NARI)活性的化合物。本发明进一步涉及一种治疗需要治疗的受试者的恶心、呕吐、反胃或其任何组合的方法,包括向所述受试者联合施用第一量的5-HT
3
拮抗剂和第二量的 NARI,其中第一量和第二量共同构成治疗有效量或各自存在治疗有效量。此外,本发明的方法还包括单独施用一种 NARI。